Advance in clinical research of febuxostat in the treatment of goutLIU Yu-yan, LI Yue-dong, TANG Jian-fei, SHEN Ru-jie, YAO Cheng-e1103-1106,1114
Improving Chinese innovation system of new drug according to 30-year history of U.S.Orphan Drug ActYI Ba-xian, WANG Guang-ping, JI Hai-hong, WU Xiao-ming1107-1114
Influencing factors and the solutions for the determination of related substances by HPLC in drug research and developmentYANG Fang1115-1117,1132
Main problems and analysis of modification of registration specifications in the supplementary applicationTIAN Jie, ZHANG Zhe-feng1118-1120,1126
Advances in strategies and clinical applications of interleukin-1 antagonistsYU Chen-lin, ZONG Ying, ZHANG Xiao-fang, YUAN Bo-jun, CUI Shu-fang, LU Guo-cai1121-1126
Uncertainty evaluation in determination of methylergometrine in human plasma by HPLC-MS/MSQI Hui-hong, LI Yang, SHI Ai-xin, HU Xin, BI Kai-shun, WANG Tie-jie1127-1132
Preparation of antisera against serotype 23F Streptococcus Pneumoniae and their specificity in immunological methods刘方蕾, 吴兵, 候亚莉, 王欣茹, 王晶, 于旭博, 刘佳, 孔素娟, 赵志强1133-1138,1145
Research advances in the pathogenesis of diabetic nephropathy and the development of anti-diabetic nephropathy agentsL(U) Meng, HU Gao-yun, TU Zhi-jun, YU Zu-tao, ZHOU Kun, LI Qian-bin1139-1145
Advance in studies on pharmacological effect and clinical application of microecologics in treating constipationLI Hui-fen1146-1148,1162
Recent advances in determination methods of drug protein bindingGUAN Jin, DING Shuang, LIU Zhi-han, DONG Xi-xin, YAN Feng, SHI Shuang1149-1153